These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 38870434

  • 1. Rapid Response to the Legalization of Fentanyl Test Strips in Alabama: An Academic-Community Partnership.
    McCollum CG, Ventrelli G, Gagnon KW, Loftis A, Famurewa A, Wimberly C, Eaton E.
    Am J Public Health; 2024 Aug; 114(8):785-788. PubMed ID: 38870434
    [Abstract] [Full Text] [Related]

  • 2. Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States.
    Peiper NC, Clarke SD, Vincent LB, Ciccarone D, Kral AH, Zibbell JE.
    Int J Drug Policy; 2019 Jan; 63():122-128. PubMed ID: 30292493
    [Abstract] [Full Text] [Related]

  • 3. Evaluating fentanyl test strips as a harm reduction strategy in rural and urban counties: study protocol for a randomized controlled trial.
    Short Mejia A, Smith GA, Fernandez SA, Freisthler B, Grella C, Michaels NL.
    Trials; 2024 Sep 04; 25(1):587. PubMed ID: 39232778
    [Abstract] [Full Text] [Related]

  • 4. A pilot study assessing client understanding and use of fentanyl test strips for harm reduction.
    Barrolle AA, Gable KN, Dell N.
    J Am Pharm Assoc (2003); 2023 Sep 04; 63(1):295-300. PubMed ID: 36280433
    [Abstract] [Full Text] [Related]

  • 5. High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips.
    Lockwood TE, Vervoordt A, Lieberman M.
    Harm Reduct J; 2021 Mar 09; 18(1):30. PubMed ID: 33750405
    [Abstract] [Full Text] [Related]

  • 6. Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study.
    Goldman JE, Waye KM, Periera KA, Krieger MS, Yedinak JL, Marshall BDL.
    Harm Reduct J; 2019 Jan 08; 16(1):3. PubMed ID: 30621699
    [Abstract] [Full Text] [Related]

  • 7. Fentanyl harm reduction strategies among Latinx communities in the United States: a scoping review.
    Luna G, Dermid G, Unger JB.
    Harm Reduct J; 2024 Aug 16; 21(1):150. PubMed ID: 39152433
    [Abstract] [Full Text] [Related]

  • 8. Fentanyl Test Strips for Harm Reduction: A Scoping Review.
    Kutscher E, Barber Grossi M, LaPolla F, Lee JD.
    J Addict Med; 2024 Aug 16; 18(4):373-380. PubMed ID: 38829042
    [Abstract] [Full Text] [Related]

  • 9. Engagement in Harm Reduction Strategies After Suspected Fentanyl Contamination Among Opioid-Dependent Individuals.
    Mistler CB, Chandra DK, Copenhaver MM, Wickersham JA, Shrestha R.
    J Community Health; 2021 Apr 16; 46(2):349-357. PubMed ID: 32997253
    [Abstract] [Full Text] [Related]

  • 10. Testing the test strips: laboratory performance of fentanyl test strips.
    Halifax JC, Lim L, Ciccarone D, Lynch KL.
    Harm Reduct J; 2024 Jan 18; 21(1):14. PubMed ID: 38238757
    [Abstract] [Full Text] [Related]

  • 11. "If I had them, I would use them every time": Perspectives on fentanyl test strip use from people who use drugs.
    Reed MK, Salcedo VJ, Guth A, Rising KL.
    J Subst Abuse Treat; 2022 Sep 18; 140():108790. PubMed ID: 35577663
    [Abstract] [Full Text] [Related]

  • 12. "You can't go wrong being safe": Motivations, patterns, and context surrounding use of fentanyl test strips for heroin and other drugs.
    Reed MK, Guth A, Salcedo VJ, Hom JK, Rising KL.
    Int J Drug Policy; 2022 May 18; 103():103643. PubMed ID: 35255392
    [Abstract] [Full Text] [Related]

  • 13. Expanding harm reduction to include fentanyl urine testing: results from a pilot in rural British Columbia.
    Mema SC, Sage C, Popoff S, Bridgeman J, Taylor D, Corneil T.
    Harm Reduct J; 2018 Apr 06; 15(1):19. PubMed ID: 29625621
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative.
    Walters SM, Baker R, Frank D, Fadanelli M, Rudolph AE, Zule W, Fredericksen RJ, Bolinski R, Sibley AL, Go VF, Ouellet LJ, Pho MT, Seal DW, Feinberg J, Smith G, Young AM, Stopka TJ.
    Harm Reduct J; 2024 Aug 24; 21(1):154. PubMed ID: 39182116
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differences in drug use behaviors that impact overdose risk among individuals who do and do not use fentanyl test strips for drug checking.
    Tilhou AS, Zaborek J, Baltes A, Salisbury-Afshar E, Malicki J, Brown R.
    Harm Reduct J; 2023 Mar 28; 20(1):41. PubMed ID: 36978170
    [Abstract] [Full Text] [Related]

  • 19. How do we understand the value of drug checking as a component of harm reduction services? A qualitative exploration of client and provider perspectives.
    Moran L, Ondocsin J, Outram S, Ciccarone D, Werb D, Holm N, Arnold EA.
    Harm Reduct J; 2024 May 11; 21(1):92. PubMed ID: 38734643
    [Abstract] [Full Text] [Related]

  • 20. Drug checking as a potential strategic overdose response in the fentanyl era.
    Laing MK, Tupper KW, Fairbairn N.
    Int J Drug Policy; 2018 Dec 11; 62():59-66. PubMed ID: 30359874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.